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• Reversible Cerebral Vasoconstriction Syndrome 
(RCVS) is a rare neurological syndrome.
• The classic presentation consists of recurrent, 
severe, ”thunderclap” headaches with neuroimaging 
findings consistent with segmental vasoconstriction 
of cerebral arteries.
• Sympathomimetics including cannabinoids have 
been found to be triggers in many cases of RCVS.
• Complications include subarachnoid hemorrhage, 
intracerebral hemorrhage, cerebral edema and 
ischemic infarction.
• To present a case of a patient with a history 
repeated tetrahydrocannabinol (THC) use led to 
recurrent multifocal ischemic infarcts and 
severe, persistent cerebral vasoconstriction 
References
• A 52 year old male with past medical history of uncontrolled 
Hypertension presented with new onset symptoms of dysarthria, left 
facial droop, left hemiparesis and severe headache.  MRI of brain 
demonstrated a right subcortical white matter stroke (Figure 1). UDS was 
positive for THC. After 8 days of inpatient stay, patient was discharged to 
rehabilitation with Aspirin 81 mg, Lipitor 80 mg, and Plavix 75 mg and 
extensively counseled on abstinence from THC. Less than 30 days later, 
the patient re-presented with new symptoms of expressive aphasia and 
right facial droop. MRI of brain demonstrated new, multiple punctate 
infarcts in the left fronto-parietal areas (Figure 2). CTA Head and Neck 
demonstrated new stenosis of the distal M1 (Figure 3). Ten days later, 
patient re-presented with altered mental status and unsteady gait. MRI 
demonstrated new infarcts in the right Middle Cerebral Artery 
distribution. The patient was hospitalized for 30 days. After 30 days of 
hospitalization, the patient was discharged on medications, Aspirin, 
Lipitor and Verpamil. Following 3 months, the patient underwent 
repeated DSA which revealed persistent multifocal narrowing throughout 
the intracranial circulation with minimal progression in the distal right 
MCA.
• This case highlights the potential devastating 
and irreversible effects of RCVS precipitated 
by exposure to a sympathomimetic agent.
• The case emphasizes the importance of 
patient counseling regarding abstinence from 
agents that may provoke RCVS.
1. Call GK, F.M., Sealfon S, et al., Reversible 
cerebral segmental vasoconstriction. . Stroke, 
(19): p. 1159-1170.
2. Chen, S.P., Fuh, J.L., Lirng, J.F., Chang, F.C. and 
Wang, S.J. , Recurrent primary thunderclap 
headache and benign CNS angiopathy: 
spectra of the same disorder? . Neurology, 
2006. 67: p. 2164-2169.
3. Chen, S.P., Fuh, J.L., Wang, S.J. , Reversible 
Cerebral Vasocosntriction Syndrome: An 
Under-recognized Clinical Emergency. .
Therapuetic Advances in Neurological 










infarcts in the left 
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